SYSergei A. Yargunin

Sergei A. Yargunin

*This is an algorithmically generated author record based on publicly available information.

Sergei A. Yargunin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Survival of Patients With Primary Cutaneous Melanoma (Stages 0-IIА and IIB-IIC), Depending on the Presence of the BRAF Mutation in the Tumor and Surgical Treatment Option

    by S. A. Yаrgunin, I. V. Reshetov, Ya. N. Shoykhet, S. I. Samoylova, O. Yu. Chukhrai, S. N. Pyatakov, V. S. Yаrgunin, Я. Н. Шойхет, О. Ю. Чухрай

    Background: Cutaneous melanoma is an extremely aggressive disease with an unpredictable prognosis. Even among patients with similar tumor parameters and extent of surgical treatment, survival may vary. The extent of surgical resection of primary cutaneous melanoma is well-established, and a BRAF mutation in the tumor is an unfavorable prognostic factor for patient survival. The mutation presence is mainly used as a marker for prescribing targeted therapy. The impact of the extent of surgery and the method for restoring a tissue defect on survival of patients with similar stages remains unexplored. The impact of the BRAF mutation in the tumor on survival of patients with cutaneous melanoma depending on the surgery method has also not been studied. We analyzed the surgical treatment outcomes of 221 patients with primary cutaneous melanoma (stages 0-IIA and IIB-IIC) who were found to have the BRAF mutation and underwent different extents of tumor excision with closure of the surgical tissue defect.Objective: To analyze the impact of the BRAF mutation in the tumor on 5-year survival of patients with primary cutaneous melanoma (stages 0-IIA and IIB-IIC), depending on the extent of surgery and the method of replacing the tissue defect.Materials and methods: We used data from 221 patients with primary cutaneous melanoma (stages 0-IIA and IIB-IIC) and assessed their BRAF mutation status, extent of tumor excision, and method of closing the tissue defect. The patients were divided into 2 groups: the main group (wide excision of the tumor and plastic replacement of the tissue defect) and the comparison group (standard margin and linear closure of the tissue defect). After surgery, all the patients underwent tumor analysis for the BRAF p.V600E/K mutation using real-time PCR. DNA was isolated using the cobas® DNA Sample Preparation Kit on a cobas® z 480 analyzer. We used the following statistical methods: frequency analysis, z test to check the equality, and Kaplan-Meier survival analysis and such software as MedCalc 12.5 (1993-2013, MedCalc Software) and SPSS 26 (IBM Corp, 2019, IBM SPSS Statistics for Windows, Armonk, NY, USA). Results: Wide excision of primary cutaneous melanoma (stages 0-IIA and IIB-IIC) was found to increase 5-year progression-free survival in patients with subsequent plastic replacement of the tissue defect compared with patients with standard margin and linear closure of the tissue defect and 5-year overall survival in patients with stage 0-IIA melanoma. In patients with 0-IIA stage melanoma and positive BRAF mutation test results, wide excision with reconstructive and plastic defect closure improved the 5-year progression-free survival. Conclusions: The 5-year progression-free survival and 5-year overall survival increased by 20.9% (P = .005) and 13.0% (P = .031), respectively, in patients who underwent wide excision of primary cutaneous melanoma followed by plastic replacement of the tissue defect compared with patients with standard excision of primary tumors and linear closure of the tissue defect. The 5-year progression-free survival increased by 23.7% (P = .017) in patients with stage IIB-IIC melanoma, regardless of the BRAF mutation. In patients with 0-IIa stage melanoma and positive BRAF mutation test results who underwent wide excision, the 5-year progression-free survival increased by 20.7% (P = .047) compared with patients who underwent tumor excision with a standard margin.

  • Open Access

    Survival of Patients With Primary Cutaneous Melanoma and the Surgical Treatment Option Based on the Level of the Surface Protein PD-L1 in the Tumor Tissue

    by S. S. Yargunin, I. V. Reshetov, Ya. N. Shoykhet, S. I. Samoylova, O. Yu. Chukhrai, S. N. Pyatakov, Я. Н. Шойхет, О. Ю. Чухрай

    Background: The PD-­L1 level is mainly used to predict the effect of drug treatment in patients with melanoma. Despite the radical nature of surgery in these patients, the rate of disease progression remains high. Therefore, it is important to study the relation between the PD-­L1 level in the tumor and surgical treatment options for cutaneous melanoma and patient survival.Objective: To analyze the effect of the PD-­L1 level in patients with primary cutaneous melanoma at different levels of tumor excision and options for closing the surgical defect.Materials and methods: We used data of 143 patients with stage 0­IIIC primary cutaneous melanoma who were randomized into 2 groups: the main group (wide excision of the tumor and plastic repair of the tissue defect) and the comparison group (standard tumor removal) with different PD-­L1 levels (IC [immune cells] %). The 5­-year survival of patients was estimated.Results: We found the mutual dependence of the PD­-L1 level and the survival of patients with stage 0-­IIC melanoma on the extent of the tissues removed and the option for closing the defect.Conclusions: The 5­year progression­free survival in patients with stage 0­IIA primary cutaneous melanoma was higher than that of those with stage IIB-­IIC melanoma regardless of the PD-­L1 level. In patients with stage 0-­IIA primary cutaneous melanoma and the low PD-­L1 level (˂5), progression­free survival was 26.3% higher (P = .013) than that of those with the high PD-­L1 level (≥5). In patients from the main group with stage 0-­IIA melanoma and the low PD­L1 level (˂5), progression­free survival was 25% higher (P = .017) and overall survival was 16.7% higher (P = .045) compared with patients from the control group with the same PD-­L1 level. In patients from the main group with stage 0­-IIC melanoma and the high PD­-L1 level (≥5), the 5-­year progression­free survival was 21.2% higher (P = .033) compared with patients from the comparison group.

  • Open Access

    Plastic surgery of skin melanoma as a factor of better survival of patients

    by S. A. Yargunin, Ya. N. Shoykhet, S. N. Pyatakov, Я. Н. Шойхет

    Introduction. Melanoma is one of the most deadly human skin tumors, and surgery remains the first and main method in its combined treatment. Despite the seemingly radical nature of surgical interventions in patients with primary skin melanoma, the frequency of locoregional recurrence and metastasis remains high.Objective. To analyze the effect on the survival rate of the use of plastic methods to close the surgical tissue defect in patients with primary melanoma of the skin after tumor removal in comparison with patients in whom plastic surgery was not used.Materials and methods. The study used data from 337 patients with stage 0-IIIc primary skin melanoma, randomized into 2 groups: the main group (with the use of plastic closure of a postoperative tissue defect) and the comparison group (with linear suturing of a tissue defect).Results. It was found that the use of plastic replacement of tissue defect in patients with localized forms of skin melanoma shows the best results of 5-year progression-free survival from 22 to 22.6% (p < 0.050), and at stage 0-IIa and in 5-year corrected overall survival rate up to 13.1% (p < 0.050).Conclusions. Performing plastic replacement of a tissue defect reduces wound edge tension and rough scarring, accelerates postoperative healing, may be an independent prognostic factor that improves progression-free survival and adjusted overall survival of patients with primary localized skin melanoma, and also be the method of choice among other methods.

  • Excised tumor checklist in cutaneous melanoma diagnostics

    by S.A. Yargunin, O.YU. Chukhrai

    Целью исследования было проанализировать влияние наглядного алгоритма описания пигментного образования на полноту описательной части, влияющей на формирование окончательного диагноза после оперативного лечения по поводу первичной или распространенной меланомы кожи. Материал и методы: исследовались пациенты с первичной и метастатической меланомой кожи (МК), пролеченные в 2009-2010 и 2013 годах (n=616), которые были рандомизированы на 2 группы методом слепого отбора на основную (n=275), в которой при описании гистологического препарата применялся наглядный алгоритм в виде бланка и группу сравнения (n= 341), в которой использована свободная форма описательной части. Результаты: установлено, что предложенный нами алгоритм в виде бланка позволяет улучшить описание опухоли от 2,6% до 99,6% по необходимым пунктам установки достоверного окончательного диагноза, что практически исключает уточняющие пересмотры гистологического материала. Обсуждение: выявлена зависимость полноты описания ключевых пунктов гистологического материала при первичной и метастатической меланоме кожи от использования алгоритма в виде унифицированного бланка регистрации. Информативность описания первичной опухоли улучшилась: в типе опухоли - на 2,6% (р=0,012), уровне инвазии по Кларку - на 4,1% (р=0,002), толщине по Бреслоу - на 6,0% (р˂0,001), наличия изъязвления - на 63,4% (р˂0,001), уровня лимфоидной инфильтрации - на 46,6% (р˂0,001), описания линии резекции - на 91,8% (р˂0,001), митозов в опухоли - на 82,1% (р˂0,001), описания периневральной инвазии - на 98,9% (р˂0,001), сосудистой инвазии - на 99,2% (р˂0,001), наличия или отсутствия транзиторных/сателлитных МТС - на 99,6% (р˂0,001). Заключение: использование алгоритма описания пигментного образования, в том числе первичной и метастатической меланомы кожи практически полностью исключает влияние человеческого фактора на включение или исключение диагноз-формирующих пунктов в описательной части гистологического...

  • Open Access

    Influence of plastic surgery for melanoma on progression-free survival in patients with skin melanoma according to the degree of tumor lymphoid infiltration

    by Sergei A. Yargunin, Ya. N. Shoykhet, A. F. Lazarev, Яргунин Сергей Анатольевич, Шойхет Я. Н.

    The aim of the study was to analyze the effect of plastic methods for closing the defect after excision of primary skin melanoma according to the degree of lymphoid infiltration of the tumor. Material and methods. Patients with primary skin melanoma (SM) treated in 2013 (n = 337) were studied; these patients were randomized into 2 groups using the method of blind selection to the main (n = 182). In these groups, the tumor removal operation in patients ended with plastic tissue defect and the group comparisons (n = 155) (after removal of the tumor, simple linear wound closure was performed). Results. It was found that pronounced lymphoid tumor infiltration in patients with primary skin melanoma as a predictor of a favorable prognosis (in terms of the occurrence of locoregional recurrence) is realized in patients with plastic defect replacement significantly 2 times more often than in patients without plastic surgery in the period from 12 to 60 months of observation. Discussion. The dependence of the occurrence of locoregional relapses in patients on lymphoid infiltration of the tumor and the performance of plastic surgery was revealed. In general, all patients who underwent plastic surgery have an advantage in terms of the occurrence of locoregional relapses in the long term for a period of up to 5 years by 12.5%. In patients with severe lymphoid infiltration and plastic surgery, locoregional relapses occur almost 2 times less often than in patients without plastic surgery, starting from a follow-up period of 1236 months by 20.6% (22.9% and 43.5%, respectively; p = 0.008), and in the period from 36 to 60 months of observation by 24.7% (25.3% and 50.0%, respectively; p = 0.002). Conclusion. The use of plastic techniques for closing a wound defect in patients with skin melanoma with pronounced lymphoid tumor infiltration reduces the risk of gross scarring and halves the risk of locoregional metastasis as compared to linear suturing of the postoperative defect.

  • Open Access

    Results of the surgical treatment of primary skin melanoma depending on the method of tumor excision and options for closing the surgical defect

    by Sergei A. Yargunin, Ya. N. Shoykhet, A. F. Lazarev, Яргунин Сергей Анатольевич, Шойхет Я. Н.

    The aim of the study was to analyze the results of the surgical treatment of patients with primary skin melanoma (SM) according to the location of the primary tumor, the type of incision, and the method of suturing the postoperative defect. Material and methods. Patients with primary SM, treated in 2013 (n = 337) were studied; these patients were randomized into two groups using the method of blind selection to the main (n = 182) comparisons (n = 155) (after removal of the tumor, simple linear wound closure was performed). Results. In patients with localized forms of SM, it was found necessary to perform a round incision when the tumor is localized on the trunk and an elliptical incision when localized on the extremities, followed by plastic replacement in all cases. In stage III patients with any tumor localization, the type of incision and suturing of the defect was not of fundamental importance. Discussion. It was revealed that patients with tumor on the trunk after rounded incision and plastic surgery had an advantage in progression-free survival (PFS) at all stages before an elliptical incision without plastic surgery during the entire observation period (123660 months) by 18.8%23%, 8%26.5% (p ˂ 0.050). Patients with localized forms of melanoma from stage 0 to IIc over the entire follow-up period of 123660 months had the greatest benefit in PFS from a round incision with plastic before conventional suturing without plastic surgery: from stage 0 to IIa by 22.0%31.8%32.0%, from stage IIb to IIc by 35.6%28.5%34.8%. In overall survival (OS), only patients with a rounded incision and plastic surgery in the initial stages of the disease stage 0 to IIa up to 36 and 60 months benefited by 24.4% and 29.3%, respectively. Compared with patients who underwent simple excision on the trunk, patients with stage IIbIIc with elliptical incisions and plasty had an advantage in PFS in the long term up to 3660 months of follow-up by 25.7% and in IDS with stages 0-IIa in the period 1236 months by 24.4%. With the localization of the primary tumor on the extremities, a statistical difference was revealed with the best indicators in patients with an elliptical incision and plastic surgery in the OS compared to patients with a rounded incision and plastic surgery in the period of 3660 months by 18.6% and 26.7%, respectively, as well as over patients with a conventional incision without plastic surgery in PFS as a whole in the subgroup at periods up to 36 and 60 months by 26.4% and 29.4% with a tendency to improve this indicator in the long term, as well as better SOS in the long term in these patients with a difference in OS of 19.3% (3660 months of observation). Conclusion. In patients with localized stages (0IIc), with the localization of the primary SM on the trunk, it is necessary to perform a round excision followed by plasty of the defect with displaced tissues; in addition, it is advisable to have an elliptical incision along the axial line for the limbs, followed by plasty of the defect. In patients with stage III, the shape of the incision and the method of suturing do not play a significant role in PFS and OS.